Literature DB >> 17504648

Update on pharmacotherapy guidelines for treatment of neuropathic pain.

J Mark Wallace1.   

Abstract

Neuropathic pain encompasses a myriad of painful disease states that are often hard to treat, especially with one single medication. In the comprehensive treatment of neuropathic pain, the concept of complex polypharmacy is a rational approach, accompanied by physical and mental health therapies. Medications primarily used for neuropathic pain generally fall into the categories of anticonvulsants, antidepressants, opioids, and topical agents. Generally, most first-line medications used today show a response rate of approximately 30% to 50% reduction in pain in up to 50% of patients treated. There is no "gold standard" in regard to one medication for neuropathic pain. Some new medications have emerged during the past few years that help to augment the armamentarium of medications used in neuropathic pain. This paper reviews the definition of neuropathic pain and introduces the reader to the evidence-based literature on these new medications available for the treatment of neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504648     DOI: 10.1007/s11916-007-0192-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  29 in total

1.  Combination therapy for neuropathic pain--which drugs, which combination, which patients?

Authors:  Srinivasa N Raja; Jennifer A Haythornthwaite
Journal:  N Engl J Med       Date:  2005-03-31       Impact factor: 91.245

2.  Pregabalin (lyrica) for neuropathic pain and epilepsy.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2005-09-12       Impact factor: 1.909

3.  Medical marijuana and the Supreme Court.

Authors:  Susan Okie
Journal:  N Engl J Med       Date:  2005-08-18       Impact factor: 91.245

Review 4.  Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.

Authors:  Anders D Westanmo; Jon Gayken; Robert Haight
Journal:  Am J Health Syst Pharm       Date:  2005-12-01       Impact factor: 2.637

5.  Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.

Authors:  H Lesser; U Sharma; L LaMoreaux; R M Poole
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

Review 6.  Management of neuropathic pain.

Authors:  Katherine E Galluzzi
Journal:  J Am Osteopath Assoc       Date:  2005-09

Review 7.  Evidence-based pharmacological treatment of neuropathic pain syndromes.

Authors:  S Beniczky; J Tajti; E Tímea Varga; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2005-06       Impact factor: 3.575

8.  Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.

Authors:  Ralph W Richter; Russell Portenoy; Uma Sharma; Linda Lamoreaux; Howard Bockbrader; Lloyd E Knapp
Journal:  J Pain       Date:  2005-04       Impact factor: 5.820

9.  Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.

Authors:  Julio Rosenstock; Michael Tuchman; Linda LaMoreaux; Uma Sharma
Journal:  Pain       Date:  2004-08       Impact factor: 6.961

10.  Pharmacotherapy for neuropathic pain: progress and prospects.

Authors:  Sandy Pullar; Alan M Palmer
Journal:  Drug News Perspect       Date:  2003-11
View more
  17 in total

Review 1.  Role of small-fiber afferents in pain mechanisms with implications on diagnosis and treatment.

Authors:  Phillip J Albrecht; Frank L Rice
Journal:  Curr Pain Headache Rep       Date:  2010-06

2.  Neuronal loss in the rostral ventromedial medulla in a rat model of neuropathic pain.

Authors:  Mai Lan Leong; Ming Gu; Rebecca Speltz-Paiz; Eleanor I Stahura; Neli Mottey; Clifford J Steer; Martin Wessendorf
Journal:  J Neurosci       Date:  2011-11-23       Impact factor: 6.167

Review 3.  Combination drug therapy for chronic pain: a call for more clinical studies.

Authors:  Jianren Mao; Michael S Gold; Miroslav Misha Backonja
Journal:  J Pain       Date:  2010-09-17       Impact factor: 5.820

Review 4.  Deep brain stimulation and motor cortical stimulation for neuropathic pain.

Authors:  James A Stadler; Damien J Ellens; Joshua M Rosenow
Journal:  Curr Pain Headache Rep       Date:  2011-02

5.  Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.

Authors:  Elizabeth K Joseph; Jon D Levine
Journal:  J Pain       Date:  2009-02-23       Impact factor: 5.820

Review 6.  Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data.

Authors:  Michael H Andreae; George M Carter; Naum Shaparin; Kathryn Suslov; Ronald J Ellis; Mark A Ware; Donald I Abrams; Hannah Prasad; Barth Wilsey; Debbie Indyk; Matthew Johnson; Henry S Sacks
Journal:  J Pain       Date:  2015-09-09       Impact factor: 5.820

7.  A Preliminary Study of Associations between Discomfort Intolerance, Pain Severity/Interference, and Frequency of Cannabis Use among Individuals with Chronic Pain.

Authors:  Jesse D Kosiba; Luke D Mitzel; Emily L Zale; Michael J Zvolensky; Joseph W Ditre
Journal:  Addict Res Theory       Date:  2019-03-23

8.  Antiallodynic Effect of Thalidomide and Morphine on Rat Spinal Nerve Ligation-induced Neuropathic Pain.

Authors:  Jeong Il Choi; Woong Mo Kim; Myung Ha Yoon; Hyung Gon Lee
Journal:  Korean J Pain       Date:  2010-08-26

9.  Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case Report.

Authors:  David J Kopsky; Jan M Keppel Hesselink
Journal:  Case Rep Med       Date:  2011-10-17

10.  Effect of sildenafil on neuropathic pain and hemodynamics in rats.

Authors:  Lan Ji Huang; Myung Ha Yoon; Jeong Il Choi; Woong Mo Kim; Hyung Gon Lee; Yeo Ok Kim
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.